For veterinary use only with a doctor's prescription

Fluvac innovator EHV1/4 is a horse vaccine provides protection against: equine influenza virus which causes equine rhinopneumonitis in horses, equine herpesvirus 1 and equine herpesvirus 4.

Composition

–Fluvac innovator EHV1/4 is the only vaccine with EIV strain KY’97 that has demonstrated protection against heterologous challenge with EIV strain OH’03.
– The only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge.
-In addition to EIV, vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
Only INNOVATOR vaccines are adjuvanted with MetaStim for improved immune response 4.

Indication

– Deliver demonstrated protection against circulating contemporary equine influenza viruses (EIV).

-Aid in the prevention of equine influenza due to type A2 viruses, and equine rhinopneumonitis due to equine herpes virus (EHV) types 1 and 4.

Dosage and administration

-Inject a 1 ml dose intramuscularly using aseptic technique.
-Administer a second to mL dose 3 to 4 weeks after the first dose in unvaccinated or naïve horses.
-A 1 mL annual revaccination in previously vaccinated horses is recommended.
-Always read and follow label indications.
-Early revaccination may be advisable when horses are faced with an outbreak or with other conditions that might make exposure likely.

STORAGE

-Store Fluvac innovator EHV1/4 in the dark at 2º to 7ºC (35º to 45ºF). AVOID FREEZING.
-SHAKE WELL.
-In some instances, transient local reactions may occur at the injection site.
-Do not vaccinate within 21 days before slaughter. In case of an anaphylactoid reaction, administer epinephrine.
-Thimerosal, neomycin, and polymyxin B are added as preservatives.